[1]
“Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections”, Reumatismo, vol. 63, no. 1, pp. 5–10, Mar. 2011, doi: 10.4081/reumatismo.2011.5.